{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:28:27Z","timestamp":1771975707189,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s10096-012-1684-9","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T07:39:28Z","timestamp":1342510768000},"page":"3191-3198","source":"Crossref","is-referenced-by-count":8,"title":["Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance"],"prefix":"10.1007","volume":"31","author":[{"given":"G.","family":"Samonis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Maraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. K.","family":"Vouloumanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. G.","family":"Georgantzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. P.","family":"Kofteridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Falagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,1]]},"reference":[{"key":"1684_CR1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","volume":"40","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Kasiakou SK (2005) Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40:1333\u20131341","journal-title":"Clin Infect Dis"},{"key":"1684_CR2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1517\/13543784.17.7.973","volume":"17","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Rafailidis PI (2008) Re-emergence of colistin in today\u2019s world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs 17:973\u2013981","journal-title":"Expert Opin Investig Drugs"},{"key":"1684_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","volume":"10","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10:43\u201350","journal-title":"Lancet Infect Dis"},{"key":"1684_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijantimicag.2008.09.001","volume":"33","author":"E Durante-Mangoni","year":"2009","unstructured":"Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME (2009) Do we still need the aminoglycosides? Int J Antimicrob Agents 33:201\u2013205","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 2","key":"1684_CR5","first-page":"7","volume":"7","author":"RN Jones","year":"1995","unstructured":"Jones RN (1995) Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity. J Chemother 7(Suppl 2):7\u201316","journal-title":"J Chemother"},{"key":"1684_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003088-200038030-00002","volume":"38","author":"M Tod","year":"2000","unstructured":"Tod M, Padoin C, Petitjean O (2000) Clinical pharmacokinetics and pharmacodynamics of isepamicin. Clin Pharmacokinet 38:205\u2013223","journal-title":"Clin Pharmacokinet"},{"key":"1684_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jac\/dkq408","volume":"66","author":"DM Livermore","year":"2011","unstructured":"Livermore DM, Mushtaq S, Warner M et al (2011) Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother 66:48\u201353","journal-title":"J Antimicrob Chemother"},{"key":"1684_CR8","first-page":"481","volume":"40","author":"TY Tsai","year":"2007","unstructured":"Tsai TY, Chang SC, Hsueh PR, Feng NH, Wang JT (2007) In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections. J Microbiol Immunol Infect 40:481\u2013486","journal-title":"J Microbiol Immunol Infect"},{"key":"1684_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/eri.11.170","volume":"10","author":"ME Falagas","year":"2012","unstructured":"Falagas ME, Karageorgopoulos DE, Georgantzi GG et al (2012) Susceptibility of Gram-negative bacteria to isepamicin: a systematic review. Expert Rev Anti Infect Ther 10:207\u2013218","journal-title":"Expert Rev Anti Infect Ther."},{"key":"1684_CR10","first-page":"291","volume-title":"Manual of clinical microbiology","author":"RB Thomson Jr","year":"2007","unstructured":"Thomson RB Jr (2007) Specimen collection, transport and processing: Bacteriology. In: Murray P, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, vol 1, 9th edn. American Society for Microbiology, Washington, pp 291\u2013333","edition":"9"},{"key":"1684_CR11","unstructured":"Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing; Seventeenth informational supplement. CLSI Document M100-S20. Wayne, PA, USA"},{"key":"1684_CR12","doi-asserted-by":"crossref","unstructured":"Members of the SFM Antibiogram Committee (2003) Comite de l\u2019Antibiogramme de la Societe Francaise de Microbiologie report. Int J Antimicrob Agents 21:364\u2013391","DOI":"10.1016\/S0924-8579(03)00021-9"},{"key":"1684_CR13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(08)70279-2","volume":"8","author":"DE Karageorgopoulos","year":"2008","unstructured":"Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8:751\u2013762","journal-title":"Lancet Infect Dis"},{"key":"1684_CR14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","volume":"14","author":"N Petrosillo","year":"2008","unstructured":"Petrosillo N, Ioannidou E, Falagas ME (2008) Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect 14:816\u2013827","journal-title":"Clin Microbiol Infect"},{"key":"1684_CR15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/CCM.0B013E3181652FAE","volume":"36","author":"DK Matthaiou","year":"2008","unstructured":"Matthaiou DK, Michalopoulos A, Rafailidis PI et al (2008) Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med 36:807\u2013811","journal-title":"Crit Care Med"},{"key":"1684_CR16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drup.2010.05.002","volume":"13","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Rafailidis PI, Matthaiou DK (2010) Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat 13:132\u2013138","journal-title":"Drug Resist Updat"},{"key":"1684_CR17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1086\/653009","volume":"50","author":"G Samonis","year":"2010","unstructured":"Samonis G, Matthaiou DK, Kofteridis D, Maraki S, Falagas ME (2010) In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece. Clin Infect Dis 50:1689\u20131691","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"1684_CR18","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/clinids\/24.Supplement_1.S46","volume":"24","author":"GH Miller","year":"1997","unstructured":"Miller GH, Sabatelli FJ, Hare RS et al (1997) The most frequent aminoglycoside resistance mechanisms\u2013changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis 24(Suppl 1):S46\u2013S62","journal-title":"Clin Infect Dis"},{"key":"1684_CR19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.48.6.2075-2080.2004","volume":"48","author":"Y Doi","year":"2004","unstructured":"Doi Y, Wachino J, Yamane K et al (2004) Spread of novel aminoglycoside resistance gene aac(6\u2032)-Iad among Acinetobacter clinical isolates in Japan. Antimicrob Agents Chemother 48:2075\u20132080","journal-title":"Antimicrob Agents Chemother"},{"key":"1684_CR20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/mdr.2010.0190","volume":"18","author":"Y Xiao","year":"2012","unstructured":"Xiao Y, Hu Y (2012) The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China. Microb Drug Resist 18:42\u201346","journal-title":"Microb Drug Resist."},{"key":"1684_CR21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jac\/dkq459","volume":"66","author":"D Landman","year":"2011","unstructured":"Landman D, Kelly P, Backer M et al (2011) Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother 66:332\u2013334","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-012-1684-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1684-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:35:01Z","timestamp":1559122501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-012-1684-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1007\/s10096-012-1684-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}